U.S. hospitals, weighing high demand and tight supplies, said they may limit use of a new Eli Lilly and Co antibody drug to COVID-19 patients with multiple risk factors for serious illness.
U.S. hospitals to restrict Lilly's COVID-19 antibody treatment due to limited supply
Post a Comment